• 한국전기전자재료학회:학술대회논문집
• /
• 한국전기전자재료학회 2005년도 추계학술대회 논문집 Vol.18
• /
• pp.187-188
• /
• 2005

In this paper, big free standing metal structures for electrostatic MEMS switches are easily fabricated using photoresist sacrificial layer. The entire process sequence, through the removal of the sacrificial layer, is kept below 150 $^{\circ}C$ to avoid curing problem of photoresist sacrificial layer. Metal structure is fabricated by thermal evaporator and a self test electrode is fabricated underlying metal suspended structure for testing by electrostatic force. The new wet release process is considered using methanol rinse, general wet release process cause stiction problem by capillary force during drying, and the yield is dramatically improved than previous wet release process using DI water rinse. The fabrication becomes much simpler and cheaper with use of a photoresist sacrificial layer.

• Archives of Pharmacal Research
• /
• 제26권6호
• /
• pp.504-510
• /
• 2003

The aim of this study is to prepare biodegradable microspheres without the use of surfactants or emulsifiers for a novel sustained delivery carriers of protein drugs. A poly($\varepsilon$-caprolactone)/poly(ethylene glycol)/poly($\varepsilon$-caprolactone) (CEC) triblock copolymer was synthesized by the ring-opening of $\varepsilon$-caprolactone with dihydroxy poly (ethylene glycol) to prepare surfactant-free microspheres. When dichloromethane (DCM) or ethyl formate (EF) was used as a solvent, the formation of microspheres did not occur. Although the microspheres could be formed prior to lyophilization under certain conditions, the morphology of microspheres was not maintained during the filtration and lyophilization process. Surfactant-free microspheres were only formed when ethyl acetate (EA) was used as the organic solvent and showed good spherical micro-spheres although the surfaces appeared irregular. The content of the protein in the micro-sphere was lower than expected, probably because of the presence of water channels and pores. The protein release kinetics showed a burst release until 2 days and after that sustained release pattern was showed. Therefore, these observations indicated that the formation of microsphere without the use of surfactant is feasible, and, this the improved process, the protein is readily incorporated in the microsphere.

• The Korean Journal of Physiology and Pharmacology
• /
• 제3권4호
• /
• pp.393-404
• /
• 1999

We have reported that hypoxia stimulates EDRF(s) release from endothelial cells and the release may be augmented by previous hypoxia. As a mechanism, it was hypothesized that reoxygenation can stimulate EDRF(s) release from endothelial cells and we tested the hypothesis via bioassay experiment. In the bioassay experiment, rabbit aorta with endothelium was used as EDRF donor vessel and rabbit carotid artery without endothelium as a bioassay test ring. The test ring was contracted by prostaglandin $F_{2a}\;(3{\times}10^{-6}\;M)$ which was added to the solution perfusing through the aorta. Hypoxia was evoked by switching the solution aerated with 95% $O_2/5%\;CO_2$ mixed gas to one aerated with 95% $O_2/5%\;CO_2$ mixed gas. Hypoxia/reoxygenation were interexchanged at intervals of 2 minutes (intermittent hypoxia). In some experiments, endothelial cells were exposed to 10-minute hypoxia (continuous hypoxia) and then exposed to reoxygenation and intermittent hypoxia. In other experiments, the duration of reoxygenation was extended from 2 minutes to 5 minutes. When the donor aorta was exposed to intermittent hypoxia, hypoxia stimulated EDRF(s) release from endothelial cells and the hypoxia-induced EDRF(s) release was augmented by previous hypoxia/reoxygenation. When the donor aorta was exposed to continuous hypoxia, there was no increase of hypoxia-induced EDRF(s) release during hypoxia. But, after the donor aorta was exposed to reoxygenation, hypoxia-induced EDRF(s) release was markedly increased. When the donor aorta was pretreated with nitro-L-arginine $(10^{-5}$ M for 30 minutes), the initial hypoxia-induced EDRF(s) release was almost completely abolished, but the mechanism for EDRF(s) release by the reoxygenation and subsequent hypoxia still remained to be clarified. TEA also blocked incompletely hypoxia-induced and hypoxia/reoxygenation-induced EDRF(s) release. EDRF(s) release by repetitive hypoxia and reoxygenation was completely blocked by the combined treatment with nitro-L-arginine and TEA. Cytochrome P450 blocker, SKF-525A, inhibited the EDRF(s) release reversibly and endothelin antgonists, BQ 123 and BQ 788, had no effect on the release of endothelium-derived vasoactive factors. Superoxide dismutase (SOD) and catalase inhibited the EDRF(s) release from endothelial cells. From these data, it could be concluded that reoxygenation stimulates EDRF(s) release and hypoxia/reoxygenation can release not only NO but also another EDRF from endothelial cells by the production of oxygen free radicals.

• Macromolecular Research
• /
• 제16권8호
• /
• pp.717-724
• /
• 2008

In this study, we prepared all-trans retinoic acid (ATRA)-encapsulated, surfactant-free, PLGA nanoparticles. The nanoparticles were formed by nanoprecipitation process, after which the solvent was removed by solvent evaporation or dialysis method. When a nanoparticle was prepared by the nanoprecipitation - solvent evaporation method, the nanoparticles were bigger than the nanoparticles of the nanoprecipitation - dialysis method, despite the higher although loading efficiency. Nanoparticles from the nanoprecipitation - dialysis method were smaller than 200 nm in diameter, while the loading efficiency was not significantly changed. Especially, nanoparticles prepared from DMAc, 1,4-dioxane, and DMF had a diameter of less than 100 nm. In the transmission electron microscopy (TEM) observations, all of the nanoparticles showed spherical shapes. The loading efficiency of ATRA was higher than 90% (w/w) at all formulations with exception of THF. The drug content was increased with increasing drug-feeding amount while the loading efficiency was decreased. In the drug release study, an initial burst was observed for $2{\sim}6$ days according to the variations of the formulation, after which the drug was continuously released over one month. Nanoparticles from the nanoprecipitation - dialysis method showed faster drug release than those from the nanoprecipitation - solvent evaporation method. The decreased drug release kinetics was observed at lower drug contents. In the tumor cell cytotoxicity test, ATRA-encapsulated, surfactant-free, PLGA nanoparticles exhibited similar cytotoxicity with that of ATRA itself.

• 폴리머
• /
• 제28권2호
• /
• pp.103-110
• /
• 2004

토코페롤을 함유하는 폴리($\varepsilon$-카프로락톤)(PCL) 마이크로캡슐은 액중건조법에 의하여 제조하였고, 제조 조건에 따른 마이크로캡슐의 특성과 PCL 필름을 사용하여 PCL의 분해거동을 측정하였다 제조된 마이크로캡슐의 크기 및 형태와 구조적 특성은 각각 SEM과 XRD를 이용하여 관찰하였다. 또한, 접촉각 측정을 통하여 심물질의 농도에 따른 마이크로캡슐의 표면자유에너지를 측정하였다. 실험결과, 마이크로캡슐은 유화제로 폴리(비닐 알코올)을 사용한 경우 안정된 구형의 마이크로캡슐이 형성되었고, 마이크로캡슐의 표면자유에너지와 PCL의 결정성은 감소하고, PCL 필름은 악 21일 후 분해가 시작되었다. 토코페롤의 방출특성은 UV/vis.에 의하여 측정하였으며, 마이크로캡슐의 방출속도는 교반속도의 증가와 함께 증가하였다. 이는 교반속도의 증가와 함께 감소된 마이크로캡슐 입자 크기에 의한 방출용액과 마이크로캡슐 사이의 계면의 증가에 의한 것으로 판단된다.

• Journal of Mechanical Science and Technology
• /
• 제18권11호
• /
• pp.1996-2008
• /
• 2004

A seamless analysis of material behavior incorporating complex geometry and crack- tip modeling is one of greatly interesting topics in engineering and computational fracture mechanics fields. However, there are still large gaps between the industrial applications and fundamental academic studies due to a time consuming detailed modeling. In order to resolve this problem, a numerical method to calculate an energy release rate by virtual crack closure technique was proposed in this paper. Both free mesh method and finite element method have been utilized and, thereafter, robust local and global elements for various geometries and boundary conditions were generated. A validity of the proposed method has been demonstrated through a series of fracture mechanics analyses without tedious crack-tip meshing.

• 대한소아치과학회지
• /
• 제49권2호
• /
• pp.197-205
• /
• 2022

이 연구는 국내에서 불소치약의 농도에 따른 불소함유 수복재의 불소 재방출량의 차이를 알아보기 위하여 시행되었다. 글라스아이오노머(Fuji IX GP EXTRA), 레진강화형 글라스아이오노머(Fuji II LC), alkasite 수복재(Cention N), 복합레진(Filtek^TM Z350XT)의 시편이 제작되었고, 1, 3, 7, 14, 21, 28일에 불소 방출량이 측정되었다. 그 후, 각 수복재에 무불소, 500 ppm, 1450 ppm의 불소치약을 적용하여 불소 재방출량을 1, 3, 7일에 측정하였다. 글라스아이오노머가 측정 7일차 까지는 가장 높은 누적 불소 방출량을 보였고, 14일차부터는 레진강화형 글라스아이오노머가 가장 높은 누적 불소 방출량을 보였으나, 두 수복재의 누적 불소 방출량의 차이는 유의하지 않았다. 500 ppm의 불소치약으로 불소 재충전 시에는 alkasite 수복재만 불소 재방출량의 차이가 유의하였고(p < 0.017), 1450 ppm의 불소치약으로 불소 재충전 시에는 모든 수복재 군이 무불소치약군에 비하여 불소 재방출량이 유의하게 높았다(p < 0.017).

• Archives of Pharmacal Research
• /
• 제13권4호
• /
• pp.293-297
• /
• 1990

Sustained release microspheres containing phenylpropanolamine HCI (PPA) were prepared with acrylic polymer (Eudragit RL/RS) sand hydroxypropylmethylcellulose phthalate (HPMCP) using a emulsion-solvent evaporation method. Magnesium strate was used a smoothing agent for preparation of microspheres. The microspheres obtained were very spherical and free-flowing particles. Scanning electron microscopy showed that microspheres have a smooth surface and a sponage-like internal structure. The dissolution rate of PPA from the microspheres was dependent on the pH of dissolution media. PPA showed faster relase in hP 1. 2 solution than in pH 7.4 solution due to the solubility of PPA. Therefore we prepared new microspheres containing 5% (w/v) HPMCP in order to control the release of PPA. The release rate of PPA from these new microspheres was similar in pH 1.2 and pH 7.4 solution.

• Nuclear Engineering and Technology
• /
• 제54권3호
• /
• pp.984-990
• /
• 2022

Corrosion release behavior of Alloy 690 in high-temperature water was investigated under the conditions of injected Zn concentrations of 0 ppb, 10 ppb and 50 ppb. A protective oxide film composed of Zn(Fe_xCr_1-x)₂O₄ and Cr₂O₃ was formed with Zn injection, resulting in a better corrosion resistance. In comparison with the Zn-free condition, the corrosion release rate under the Zn-injection conditions was smaller. The corrosion release inhibiting factors were 1.7 and 1.9 under the conditions of 10 ppb and 50 ppb Zn-injection respectively. A foreseen application of the corrosion and corrosion release rates has been proposed and discussed.

• Journal of Pharmaceutical Investigation
• /
• 제19권2호
• /
• pp.99-107
• /
• 1989

In order to develop a pediatric liquid preparation with sustained release properties, dextromethorphan hydrobromide (DEXT) was complexed with strong cation exchange resin (CG 120) and the-complex was coated with Eudragit RS using a phase separation method by non-solvent addition. The effect of pH, ionic strength of the release medium and drug/resin ratio on the release rate of DEXT was studied. The release rate of free drug from the uncoated complex, and coated complexes with 9.5 and 18.5% Eudragit RS in artificial gastric juice were measured. The release rate from the uncoated complex was faster with higher pH, higher ionic strength of the release medium and higher drug/resin ratio. The release rate from the coated complex could be controlled by the amount of coating material, and the surface after release did not rupture into.